Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Primary progressive multiple sclerosis: a distinct syndrome?

G V McDonnell1, S A Hawkins

  • 1Royal Victoria Hospital, Belfast, Northern Ireland.

Multiple Sclerosis (Houndmills, Basingstoke, England)
|October 1, 1996
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

A rare characteristic neuroimaging pattern in hyperammonaemia.

The Ulster medical journal·2017
Same author

Acute neuromuscular respiratory failure: a population-based study of aetiology and outcome in Northern Ireland.

Postgraduate medical journal·2014
Same author

Immunological faecal occult blood testing: a discriminatory test to identify colorectal cancer in symptomatic patients.

International journal of surgery (London, England)·2013
Same author

Paraneoplastic sensorimotor neuropathy associated with regression of small cell lung carcinoma.

BMJ case reports·2012
Same author

Transient cardiomyopathy as the presenting feature of acute disseminated encephalomyelitis.

Multiple sclerosis (Houndmills, Basingstoke, England)·2009
Same author

Self-trapping of planar optical beams by use of the photorefractive effect in InP:Fe.

Optics letters·2009
Same journal

Impact of multiple sclerosis disease-modifying therapies on chronic lesion tissue expansion.

Multiple sclerosis (Houndmills, Basingstoke, England)·2026
Same journal

Tobacco smoking disrupts bile acid and tryptophan metabolism in multiple sclerosis.

Multiple sclerosis (Houndmills, Basingstoke, England)·2026
Same journal

Missed radiologic disease activity by conventional side-by-side MRI comparison is associated with future disease activity in multiple sclerosis: Adopting semiautomated coregistration-fusion into clinical practice.

Multiple sclerosis (Houndmills, Basingstoke, England)·2026
Same journal

Longitudinal magnetic resonance spectroscopy study of metabolite changes over 2 years in relapsing and primary progressive multiple sclerosis treated with ocrelizumab.

Multiple sclerosis (Houndmills, Basingstoke, England)·2026
Same journal

Racial identity, marginalization, and depression in pediatric-onset multiple sclerosis.

Multiple sclerosis (Houndmills, Basingstoke, England)·2026
Same journal

Disability and race in MS: Does socioeconomic disadvantage play a role?

Multiple sclerosis (Houndmills, Basingstoke, England)·2026
See all related articles

Multiple sclerosis (MS) presents diverse clinical courses, including relapsing-remitting and progressive forms. This review explores distinct profiles of primary progressive MS versus other subtypes, impacting diagnosis and treatment trials.

Area of Science:

  • Neurology
  • Immunology
  • Clinical Medicine

Background:

  • Multiple sclerosis (MS) is recognized for relapsing-remitting and progressive clinical courses.
  • Progressive MS is further classified into primary progressive MS (PPMS) and secondary progressive MS (SPMS).
  • Emerging evidence suggests distinct differences among MS subtypes in clinical, epidemiological, and pathological aspects.

Purpose of the Study:

  • To review current criteria for classifying MS patients and highlight the need for standardized nomenclature.
  • To evaluate whether primary progressive MS (PPMS) exhibits a unique profile compared to other MS categories.
  • To examine the implications of MS subtype diversity for differential diagnoses and future therapeutic trials.

Main Methods:

  • Literature review of existing classification criteria for multiple sclerosis.

Related Experiment Videos

  • Comparative analysis of clinical features, epidemiology, pathogenesis, genetics, and neuroimaging across MS subtypes.
  • Evaluation of diagnostic criteria and therapeutic trial designs in the context of MS heterogeneity.

    • Main Results:

    • MS exhibits significant diversity beyond clinical course, with potential differences in clinical presentation, epidemiology, pathogenesis, genetics, and neuroimaging.
    • Primary progressive MS (PPMS) may represent a distinct entity with unique characteristics.
    • Current classification systems and nomenclature for MS subtypes require refinement.

    Conclusions:

    • Recognizing the distinct profiles of MS subtypes, particularly PPMS, is crucial for accurate diagnosis and effective treatment.
    • Further research is needed to elucidate the specific differences between MS subtypes.
    • A clear and consistent nomenclature is essential for advancing MS research and clinical management, especially for therapeutic trials.